Free Trial
NASDAQ:SDGR

Schrödinger (SDGR) Stock Price, News & Analysis

Schrödinger logo
$25.08 -0.35 (-1.38%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$25.08 0.00 (-0.02%)
As of 01/31/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Schrödinger Stock (NASDAQ:SDGR)

Key Stats

Today's Range
$24.88
$26.22
50-Day Range
$18.69
$25.52
52-Week Range
$16.67
$33.63
Volume
778,173 shs
Average Volume
860,250 shs
Market Capitalization
$1.83 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.11
Consensus Rating
Moderate Buy

Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Schrödinger Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
36th Percentile Overall Score

SDGR MarketRank™: 

Schrödinger scored higher than 36% of companies evaluated by MarketBeat, and ranked 785th out of 957 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Schrödinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Schrödinger has only been the subject of 2 research reports in the past 90 days.

  • Read more about Schrödinger's stock forecast and price target.
  • Earnings Growth

    Earnings for Schrödinger are expected to grow in the coming year, from ($2.37) to ($2.08) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Schrödinger is -10.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Schrödinger is -10.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Schrödinger has a P/B Ratio of 3.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Schrödinger's valuation and earnings.
  • Percentage of Shares Shorted

    13.48% of the outstanding shares of Schrödinger have been sold short.
  • Short Interest Ratio / Days to Cover

    Schrödinger has a short interest ratio ("days to cover") of 12.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Schrödinger has recently increased by 2.72%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Schrödinger does not currently pay a dividend.

  • Dividend Growth

    Schrödinger does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.48% of the outstanding shares of Schrödinger have been sold short.
  • Short Interest Ratio / Days to Cover

    Schrödinger has a short interest ratio ("days to cover") of 12.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Schrödinger has recently increased by 2.72%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Schrödinger has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Schrödinger this week, compared to 4 articles on an average week.
  • Search Interest

    Only 6 people have searched for SDGR on MarketBeat in the last 30 days. This is a decrease of -45% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Schrödinger insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.60% of the stock of Schrödinger is held by insiders.

  • Percentage Held by Institutions

    79.05% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Schrödinger's insider trading history.
Receive SDGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter.

SDGR Stock News Headlines

Scientists working in laboratory and testing samples — Photo
AI Pharma: 2 Paths to AI-Powered Drug Investment (SDGR)
AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.
Is this Elon’s true agenda?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them
FY2024 EPS Estimates for Schrödinger Decreased by Analyst
See More Headlines

SDGR Stock Analysis - Frequently Asked Questions

Schrödinger's stock was trading at $19.29 on January 1st, 2025. Since then, SDGR stock has increased by 30.0% and is now trading at $25.08.
View the best growth stocks for 2025 here
.

Schrödinger, Inc. (NASDAQ:SDGR) announced its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.40) by $0.12. The business's revenue was down 17.1% compared to the same quarter last year.

Schrödinger (SDGR) raised $150 million in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO.

Schrödinger's top institutional investors include Sumitomo Mitsui Trust Group Inc. (4.82%), Stephens Investment Management Group LLC (2.21%), Baillie Gifford & Co. (1.45%) and Principal Financial Group Inc. (0.37%). Insiders that own company stock include Ramy Farid, Kenneth Patrick Lorton, Margaret Dugan, Yvonne Tran, Jenny Herman, Robert Lorne Abel and Nancy Thornberry.
View institutional ownership trends
.

Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Schrödinger investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
11/12/2024
Today
2/01/2025
Next Earnings (Estimated)
2/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SDGR
Fax
N/A
Employees
790
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$32.11
High Stock Price Target
$50.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+28.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$40.72 million
Pretax Margin
-92.05%

Debt

Sales & Book Value

Annual Sales
$216.67 million
Cash Flow
$0.64 per share
Book Value
$7.60 per share

Miscellaneous

Free Float
66,593,000
Market Cap
$1.83 billion
Optionable
Optionable
Beta
1.59
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:SDGR) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners